Literature DB >> 27432064

Naringenin inhibits spinal cord injury-induced activation of neutrophils through miR-223.

Long-Bao Shi1, Pei-Fu Tang2, Wei Zhang1, Yan-Peng Zhao1, Li-Cheng Zhang1, Hao Zhang1.   

Abstract

Naringenin (NR), a flavonoid abundant in citrus fruits has been reported to possess anti-inflammatory properties. The present study aimed to investigate the protective of naringenin in rats after spinal cord injury (SCI) and the underlying mechanisms associated with neuroinflammation. Adult male Sprague-Dawley rats were subjected to laminectomy at T9-T11 and compression with a vascular clip. The spinal cords spanning the injury site about 0.8cm were collected for testing. There were five groups (n=7 in each group): (a) Control group; (b) sham group group; (c) SCI+saline; (d) SCI+NR (50mg/kg, p.o.) group and (e) SCI+NR (100mg/kg, p.o.) group. Different doses of NR (50mg/kg, p.o. and 100mg/kg, p.o.) or saline were administered once daily for 11 consecutive days, from 3days prior to surgery to 7days after surgery. The expression level of miR-223, NLRP3 and IL-1β were measured by RT- qPCR. The accumulation of neutrophils at the site of compression, as evaluated by measuring the tissue myeloperoxidase activity, significantly increased with time following the compression, peaking at 24h post compression. The expression of miR-223 was significant elevated in (b). However, spinal cord myeloperoxidase activity and the expression of miR-223 did not increase in sham-operated animals. NR significantly inhibited a SCI-induced activation of neutrophils through repressed miR-223 in group (d) and (e). There was a better effect in group (e) than group (d). miR-223 is thought to act as a fine-tuner of granulocyte production and the inflammatory response. Our findings suggested that repeated administration of naringenin (100mg/kg, p.o) may provide the protective effect of the spinal cord injury in rats, possibly through inhibiting neuroinflammation.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Naringenin; Neutrophils; Spinal cord injury; miR-223

Mesh:

Substances:

Year:  2016        PMID: 27432064     DOI: 10.1016/j.gene.2016.07.037

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  15 in total

Review 1.  MicroRNA-based therapeutics in central nervous system injuries.

Authors:  Ping Sun; Da Zhi Liu; Glen C Jickling; Frank R Sharp; Ke-Jie Yin
Journal:  J Cereb Blood Flow Metab       Date:  2018-04-30       Impact factor: 6.200

2.  EPO-cyclosporine combination therapy reduced brain infarct area in rat after acute ischemic stroke: role of innate immune-inflammatory response, micro-RNAs and MAPK family signaling pathway.

Authors:  Chun-Man Yuen; Kuo-Ho Yeh; Christopher Glenn Wallace; Kuan-Hung Chen; Hung-Sheng Lin; Pei-Hsun Sung; Han-Tan Chai; Yung-Lung Chen; Cheuk-Kwan Sun; Chih-Hung Chen; Gour-Shenq Kao; Sheung-Fat Ko; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

3.  Intrathecal administration of naringenin improves motor dysfunction and neuropathic pain following compression spinal cord injury in rats: relevance to its antioxidant and anti-inflammatory activities.

Authors:  Sajad Fakhri; Shahryar Sabouri; Amir Kiani; Mohammad Hosein Farzaei; Khodabakhsh Rashidi; Ahmad Mohammadi-Farani; Ehsan Mohammadi-Noori; Fatemeh Abbaszadeh
Journal:  Korean J Pain       Date:  2022-07-01

4.  The inhibition of miR-17-5p promotes cortical neuron neurite growth via STAT3/GAP-43 pathway.

Authors:  Liang Zhang; Zhijie Wang; Bo Li; Ziwei Xia; Xin Wang; Yucai Xiu; Zheng Zhang; Chuanjie Chen; Hong Song; Wenhua Li; Mei Yu; Meiling Zhang; Kai Wang; Xiaoling Guo; Liqun Ren; Tianyi Wang
Journal:  Mol Biol Rep       Date:  2020-02-24       Impact factor: 2.316

5.  Repair mechanism of astrocytes and non-astrocytes in spinal cord injury.

Authors:  Xiang-Yun Liu; Jian-Wei Guo; Jian-Qiang Kou; Yuan-Liang Sun; Xiu-Jun Zheng
Journal:  World J Clin Cases       Date:  2020-03-06       Impact factor: 1.337

6.  Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3/NF-κB pathway in mice.

Authors:  Qinyu Wang; Yangjie Ou; Guomin Hu; Cong Wen; Shanshan Yue; Cong Chen; Lu Xu; Jiawei Xie; Hui Dai; Han Xiao; Youyi Zhang; Rong Qi
Journal:  Br J Pharmacol       Date:  2020-01-30       Impact factor: 8.739

Review 7.  Therapeutic potential of IKK-β inhibitors from natural phenolics for inflammation in cardiovascular diseases.

Authors:  Peng Zhou; Fang Hua; Xiang Wang; Jin-Ling Huang
Journal:  Inflammopharmacology       Date:  2020-01-01       Impact factor: 4.473

Review 8.  On the Neuroprotective Effects of Naringenin: Pharmacological Targets, Signaling Pathways, Molecular Mechanisms, and Clinical Perspective.

Authors:  Zeinab Nouri; Sajad Fakhri; Fardous F El-Senduny; Nima Sanadgol; Ghada E Abd-ElGhani; Mohammad Hosein Farzaei; Jen-Tsung Chen
Journal:  Biomolecules       Date:  2019-11-03

Review 9.  Neutrophil, Extracellular Matrix Components, and Their Interlinked Action in Promoting Secondary Pathogenesis After Spinal Cord Injury.

Authors:  Sonam Dolma; Hemant Kumar
Journal:  Mol Neurobiol       Date:  2021-06-22       Impact factor: 5.590

10.  Targeting the NLRP3 inflammasome to attenuate spinal cord injury in mice.

Authors:  Wu Jiang; Maoqiang Li; Fan He; Shaobo Zhou; Liulong Zhu
Journal:  J Neuroinflammation       Date:  2017-10-25       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.